Molnupiravir COVID-19 Medicine: Merck’s COVID-19 drug shows 50% efficacy in reducing hospitalization and deaths

Merck and Ridgeback Biotherapeutics announced its new anti-viral drug Molnupiravir to treat COVID-19 infection. All you need to know



source https://www.jagranjosh.com/current-affairs/molnupiravir-covid19-medicine-mercks-covid19-drug-shows-50-efficacy-in-reducing-hospitalization-and-deaths-1633416515-1

Comments

Check These Popular Posts